MedTrace Logo

Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity

NCT02733484 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-03-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether the probiotics will be effective in the treatment of obesity

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotics

the patients in this arm will receive probiotics with a dose for 2g/d for 3 months.

DIETARY_SUPPLEMENT

Placebo

the patients in this arm will receive placebo intervention

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Huanlong Qin · Shanghai 10th People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02733484 on ClinicalTrials.gov